Bionano is in the process of completing its ... to traditional cytogenetics and our technologies; the impact of our Stratys system and VIA software to increase throughput and simplify analysis ...

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform ...

The latest update is out from BioNano Genomics ( (BNGO)). Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with ...

Bionano Genomics, Inc. announced a groundbreaking study published in Modern Pathology, which highlights the effectiveness of optical genome mapping (OGM) in detecting bone and soft tissue tumors ...

Short interest in Bionano Genomics Inc (NASDAQ:BNGO) increased during the last reporting period, rising from 15.84M to 17.65M. This put 12.63% of the company's publicly available shares short.

Bionano is in the process of completing its customary year ... and its utility compared to traditional cytogenetics and our technologies; the impact of our Stratys system and VIA software to increase ...